Goldman Sachs’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $565K | Sell |
|
|||||
|
2025
Q1 | $837K | Sell |
|
|||||
|
2024
Q4 | $4.93M | Buy |
|
|||||
|
2024
Q3 | $1.35M | Buy |
|
|||||
|
2024
Q2 | $475K | Buy |
|
|||||
|
2024
Q1 | $245K | Sell |
|
|||||
|
2023
Q4 | $273K | Buy |
|
|||||
|
2023
Q3 | $202K | Sell |
|
|||||
|
2023
Q2 | $323K | Sell |
|
|||||
|
2023
Q1 | $684K | Sell |
|
|||||
|
2022
Q4 | $5.44M | Sell |
|
|||||
|
2022
Q3 | $7.09M | Buy |
|
|||||
|
2022
Q2 | $5.43M | Buy |
|
|||||
|
2022
Q1 | $4.18M | Hold |
|
|||||
|
2021
Q4 | $7.63M | Buy |
|